Positive (1-->3)-beta-D-glucan in blood components and release of (1-->3)-beta-D-glucan from depth-type membrane filters for blood processing

Transfusion

Volumn 42, Issue 9, 2002, Pages 1189-1195

  Usami, Makoto ^a,b,c,d   Ohata, Atsushi ^a,b,c,d   Horiuchi, Takeshi ^a,b,c,d   Nagasawa, Koichi ^a,b,c,d   Wakabayashi, Toshio ^a,b,c,d   Tanaka, Shigenori ^a,b,c,d  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF EAST ASIA   (Japan)

^c SRL INC   (Japan)

^d SEIKAGAKU CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BETA 1,3 GLUCAN; BETA GLUCAN; BETA-1,3-GLUCAN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR; CELLULOSE; ENDOTOXIN; GLUCAN; GLYCOSIDASE; IMMUNOGLOBULIN; PLASMA PROTEIN; SERUM ALBUMIN;

ANALYTICAL EQUIPMENT; ARTICLE; ARTIFACT; ARTIFICIAL MEMBRANE; BLOOD; BLOOD COMPONENT THERAPY; CELL WALL; CHEMISTRY; FILTRATION; FUNGUS; HUMAN; LABORATORY DIAGNOSIS; METABOLISM; MYCOSIS; SOLUBILITY; SOLUTION AND SOLUBILITY;

ARTIFACTS; BACTERIAL PROTEINS; BETA-GLUCANS; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; BLOOD COMPONENT TRANSFUSION; BLOOD PROTEINS; CELL WALL; CELLULOSE; ENDOTOXINS; FALSE POSITIVE REACTIONS; FILTRATION; FUNGI; GLUCANS; GLYCOSIDE HYDROLASES; HUMANS; IMMUNOGLOBULINS; MEMBRANES, ARTIFICIAL; MYCOSES; REAGENT KITS, DIAGNOSTIC; SERUM ALBUMIN; SOLUBILITY; SOLUTIONS;

EID: 0036725304     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2002.00162.x     Document Type: Article

References (17)

1. 1 Obayashi T, Yoshida M, Mori T, et al. Plasma (1→3)‐β‐d‐glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995 ; 345: 17 ‐ 20.
2. 2 Kohno S, Mitsutake K, Maesaki S, et al. An evaluation of serodiagnostic tests in patients with candidemia: (1→3)‐β‐d‐glucan, mannan, candida antigen by Cand‐Tec, and d‐arabinitol. Microbiol Immunol 1993 ; 37: 207 ‐ 12.
3. 3 Hossain MA, Miyazaki T, Mitsutake K, et al. Comparison between Wako‐WB003 and Fungitec G tests for detection of (1→3)‐β‐d‐glucan in systemic mycosis. J Clin Lab Anal 1997 ; 11: 73 ‐ 7.
4. 4 Petri MG, Konig J, Moecke HP, et al. Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non‐neutropenic patients. Paul‐Ehrlich Society for Chemotherapy, Division of Mycology and Pneumonia Research. Intens Care Med 1997 ; 23: 317 ‐ 25.
5. 5 Nassoura Z, Ivatury RR, Simon RJ, Jabbour N, Stahl WM. Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy. J Trauma 1993 ; 35: 290 ‐ 5.
6. 6 Inoue Y, Kohno S, Fujii T, et al. Clinical evaluation of catheter‐related fungemia and bacteremia. Intern Med 1995 ; 34: 485 ‐ 90.
7. 7 Ikemura K, Ikegami K, Shimazu T, Yoshioka T, Sugimoto T. False‐positive result in Limulus test caused by Limulus amebocyte lysate‐reactive material in immunoglobulin products. J Clin Microbiol 1989 ; 27: 1965 ‐ 8.
8. 8 Miyazaki T, Kohno S, Koga H, et al. G test, a new direct method for diagnosis of Candida infection: comparison with assay for beta‐glucan and mannan antigen in a rabbit model of systemic candidiasis. J Clin Lab Anal 1992 ; 6: 315 ‐ 8.
9. 9 Yamagami S, Yoshihara H, Kishimoto T, et al. Cuprophan membrane induces interleukin‐1 activity. Trans Am Soc Artif Intern Organs 1986 ; 32: 98 ‐ 101.
10. 10 Yoshioka T, Ikegami K, Ikemura K, et al. A study on Limulus amebocyte lysate (LAL) reactive material derived from dialyzers. Jpn J Surg 1989 ; 19: 38 ‐ 41.
11. 11 Yoshida K, Nakajima M, Yamasaki M, et al. Investigation of influence of hemodialysis membranes and factors associated with hemodialysis on serum (1→3)‐β‐d‐glucan [in Japanese]. Jpn J Infect 1998 ; 72: 245 ‐ 8.
12. 12 Obayashi T, Tamura H, Tanaka S, et al. A new chromogenic endotoxin‐specific assay using recombined limulus coagulation enzymes and its clinical applications. Clin Chim Acta 1985 ; 149: 55 ‐ 65.
13. 13 Tanaka S, Aketagawa J, Takahashi S, Shibata Y. Activation of a limulus coagulation factor G by (1→3)‐β‐d‐glucans. Carbohydr Res 1991 ; 218: 167 ‐ 74.
14. 14 Aketagawa J, Tanaka S, Tamura H, Shibata Y, Saito H. Activation of limulus coagulation factor G by several (1→3)‐β‐d‐glucans: comparison of the potency of glucans with identical degree of polymerization but different conformations. J Biochem 1993 ; 113: 683 ‐ 6.
15. 15 Stone BA, Clarke AE. Structural characterization and physical chemistry of (1→3)‐β‐glucans. In: Stone BA, Clarke AE, editors. Chemistry and biology of (1→3)‐β‐ d ‐glucans. Melbourne, Australia: La Trobe University Press; 1992. p. 1‐116.
16. 16 Miura T, Ohno N, Miura NN, Shimada S, Yadomae T. Inactivation of a particle β‐glucan by proteins in plasma and serum. Biol Pharm Bull 1997 ; 20: 1103 ‐ 7.
17. 17 Williams DL, Mueller A, Browder W. Glucan‐based macrophage stimulators: A review of their anti‐infective potential. Clin Immunother 1996 ; 5: 392 ‐ 9.